Pharmaceutical Preparations · DE · CIK 1759425
Mirum Pharmaceuticals transforms rare disease treatment with approved medicines and pipeline candidates
Comparable business profile · signals at a glance
In the 90 days to Mar 16, 2026: 1 insider bought $9.0M · 7 sold $16.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER | Sell | 40,985 | $91.98 | $3.8M |
| Mar 16, 2026 | Radovich PeterPRESIDENT AND COO | Sell | 16,515 | $91.98 | $1.5M |
| Mar 16, 2026 | Bjerkholt EricCHIEF FINANCIAL OFFICER | Sell | 7,287 | $91.98 | $670K |
| Mar 16, 2026 | Quan JoanneCHIEF MEDICAL OFFICER | Sell | 7,287 | $91.98 | $670K |
| Mar 16, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER | Sell | 4,732 | $91.98 | $435K |
| Mar 16, 2026 | Ramasastry SairaDirector | Sell | 2,000 | $90.76 | $182K |
| Feb 13, 2026 | Ramasastry SairaDirector | Sell | 2,000 | $102.09 | $204K |
| Feb 2, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER | Sell | 9,108 | $103.30 | $941K |
| Feb 2, 2026 | Radovich PeterPRESIDENT AND COO | Sell | 2,631 | $103.30 | $272K |
| Feb 2, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER | Sell | 968 | $103.30 | $100K |
| Jan 26, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER | Sell | 6,831 | $96.19 | $657K |
| Jan 26, 2026 | Radovich PeterPRESIDENT AND COO | Sell | 3,143 | $96.19 | $302K |
| Jan 26, 2026 | Bjerkholt EricCHIEF FINANCIAL OFFICER | Sell | 1,053 | $96.19 | $101K |
| Jan 26, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER | Sell | 842 | $96.19 | $81K |
| Jan 23, 2026 | Heron Patrick JDirector | Buy | 131,425 | $68.48 | $9.0M |
| Jan 22, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER | Sell | 7,098 | $93.33 | $662K |
| Jan 22, 2026 | Radovich PeterPRESIDENT AND COO | Sell | 2,382 | $93.33 | $222K |
| Jan 22, 2026 | Quan JoanneCHIEF MEDICAL OFFICER | Sell | 1,822 | $93.33 | $170K |
| Jan 22, 2026 | Bjerkholt EricCHIEF FINANCIAL OFFICER | Sell | 1,421 | $93.33 | $133K |
| Jan 22, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER | Sell | 926 | $93.33 | $86K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.